News
1 minute read

MBHB Partner Kevin Noonan Quoted In BioNews Article Entitled, “Broad Institute Responds To Berkeley CRISPR Patent Appeal”

Kevin E. Noonan, Ph.D.October 30, 2017

McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Kevin E. Noonan is quoted in an October 30, 2017 BioNews article entitled, “Broad Institute responds to Berkeley CRISPR patent appeal.” The Broad Institute has filed arguments ahead of the upcoming CRISPR patent appeal hearing. This marks the latest development in ongoing dispute over the US patent for CRISPR/Cas9 between the University of California at Berkeley (UC), and the University of Vienna and Professor Emmanuelle Charpentier, against the Broad Institute of MIT and Harvard in Cambridge, Massachusetts, regarding who has the right to a patent on the eukaryotic application of CRISPR/Cas9 technology. View the article